ArTS Archivio della ricerca di Trieste

Crocè, Saveria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.597
EU - Europa 6.366
AS - Asia 4.223
SA - Sud America 705
AF - Africa 189
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 14
Totale 22.109
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.361
IT - Italia 1.414
CN - Cina 1.318
SG - Singapore 1.307
PL - Polonia 1.087
SE - Svezia 830
HK - Hong Kong 716
UA - Ucraina 605
DE - Germania 585
BR - Brasile 572
GB - Regno Unito 313
FI - Finlandia 280
RU - Federazione Russa 257
VN - Vietnam 199
FR - Francia 195
BG - Bulgaria 192
TR - Turchia 176
NL - Olanda 175
CA - Canada 167
KR - Corea 163
IE - Irlanda 162
IN - India 87
CH - Svizzera 65
MA - Marocco 55
SN - Senegal 54
AR - Argentina 52
BD - Bangladesh 44
MX - Messico 44
BE - Belgio 43
JP - Giappone 33
AT - Austria 30
ES - Italia 27
EG - Egitto 26
IQ - Iraq 26
EC - Ecuador 23
ZA - Sudafrica 23
CZ - Repubblica Ceca 22
ID - Indonesia 21
LT - Lituania 19
IR - Iran 15
PK - Pakistan 15
PY - Paraguay 14
RO - Romania 14
CO - Colombia 13
SA - Arabia Saudita 12
AU - Australia 11
KE - Kenya 11
PH - Filippine 11
DK - Danimarca 10
EU - Europa 10
CL - Cile 9
IL - Israele 9
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
LK - Sri Lanka 7
UY - Uruguay 7
HR - Croazia 6
JO - Giordania 6
TN - Tunisia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BO - Bolivia 5
DO - Repubblica Dominicana 5
GE - Georgia 5
GR - Grecia 5
NP - Nepal 5
TW - Taiwan 5
AM - Armenia 4
ET - Etiopia 4
KG - Kirghizistan 4
KZ - Kazakistan 4
NG - Nigeria 4
PE - Perù 4
PT - Portogallo 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
VE - Venezuela 4
CR - Costa Rica 3
GT - Guatemala 3
HU - Ungheria 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
AL - Albania 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BZ - Belize 2
CU - Cuba 2
DZ - Algeria 2
EE - Estonia 2
GA - Gabon 2
GY - Guiana 2
JM - Giamaica 2
MO - Macao, regione amministrativa speciale della Cina 2
MT - Malta 2
NO - Norvegia 2
OM - Oman 2
PA - Panama 2
RS - Serbia 2
TH - Thailandia 2
BB - Barbados 1
BH - Bahrain 1
Totale 22.095
Salva come PNG Salva come JPEG
Città #
Warsaw 1.062
Ashburn 982
Woodbridge 969
Fairfield 933
Ann Arbor 875
Chandler 828
Houston 827
Hong Kong 704
Singapore 557
Jacksonville 555
Wilmington 459
Trieste 448
Seattle 430
Hefei 380
Beijing 340
Cambridge 304
Princeton 259
Boardman 240
Sofia 192
Dublin 158
Seoul 155
Los Angeles 152
Columbus 151
Izmir 151
Dallas 147
London 134
Toronto 112
Munich 106
Moscow 104
Santa Clara 83
Dearborn 79
Buffalo 78
Milan 78
Frankfurt am Main 67
San Diego 66
Ho Chi Minh City 62
Falls Church 58
São Paulo 57
Helsinki 56
New York 56
Dakar 54
Düsseldorf 53
Bern 52
Casablanca 45
Chicago 44
Rome 44
Venezia 42
Brussels 40
Dong Ket 40
Redmond 40
Turku 39
Hanoi 38
Redwood City 38
Des Moines 36
Phoenix 32
Udine 30
Krefeld 29
Nuremberg 29
Redondo Beach 29
Stockholm 25
Verona 25
Tokyo 24
Shanghai 23
Vienna 23
Amsterdam 22
Atlanta 22
Denver 22
The Dalles 22
Montreal 21
Rio de Janeiro 21
Bremen 20
Grafing 20
Mexico City 20
Chennai 19
Mestre 19
Norwalk 19
Boston 18
Orem 18
Brooklyn 17
Guangzhou 17
Jinan 17
Lauterbourg 17
Portsmouth 17
San Francisco 17
Washington 17
Kunming 16
Roubaix 16
Venice 16
Belo Horizonte 15
Ottawa 15
Wroclaw 15
Fremont 14
Oklahoma City 14
Johannesburg 13
Nanjing 13
Brno 12
Dhaka 12
Lozzo di Cadore 12
Nanchang 12
Naples 12
Totale 14.937
Salva come PNG Salva come JPEG
Nome #
MBL2 Genetic Variants in HCV Infection Susceptibility, Spontaneous Viral Clearance and Pegylated Interferon Plus Ribavirin Treatment Response 435
The role of multipotent cancer associated fibroblasts in hepatocarcinogenesis 397
Transcriptional Up-Regulation of APE1/Ref-1 in hepatic tumor: Role in hepatocytes resistance to oxidative stress and apoptosis 374
Adverse reactions of direct-acting antiviral agents in HCV patients: Our experience 349
Serum Stem Cell Growth Factor Beta for the Prediction of Therapy Response in Hepatocellular Carcinoma 346
MicroRNAs as Regulators of Neo-Angiogenesis in Hepatocellular Carcinoma 338
The Role of Liver and Spleen Elastography in the Screening of Esophageal Varices in Patients with Liver Cirrhosis: Do We Really Need Endoscopy? 332
Evaluation of spleen stiffness in healthy volunteers using point shear wave elastography 328
Serum AP-endonuclease 1 (sAPE1) as novel biomarker for hepatocellular carcinoma 304
Gut microbiota characterisation in obese patients before and after bariatric surgery 286
Abnormal apolipoprotein B pre-mRNA splicing in patients with familial hypobetalipoproteinaemia 235
A new insight on the stem cell growth factor beta as astrong predictor of therapy response in hepatocellular carcinoma 231
Anatomy of Basal Ganglia and Thalamus 227
HBV, HCV, and TTV detection by in situ polymerase chain reaction could reveal occult infection in hepatocellular carcinoma: comparison with blood markers 218
Identification and evaluation of novel non-invasive biomarkers for non-alcoholic fatty liver disease 217
CD209 promoter polymorphisms associate with HCV infection and pegylated-interferon plus ribavirin treatment response 216
1H-NMR Spectroscopic Studies of Lipid Extracts from Human Fatty Liver 212
NOVEL BIOMARKERS FOR THE DIAGNOSIS OF LIVER FIBROSIS IN A HIGHLY RISK NAFLD COHORT in IFSO 2017 22(nd) World Congress 208
TACE with cone beam computed tomography is more effective than traditional technique in BCLC A HCC patients ineligible to surgery 206
Role of SERPINB3 like serological and molecular biomarker into NASH development and progression 206
Gene and functional up-regulation of the BCRP/ABCG2 transporter in hepatocellular carcinoma. 203
A simple in silico strategy identifies candidate biomarkers for the diagnosis of liver fibrosis in morbidly obese subjects 193
Bariatric surgery drives major rearrangements of the intestinal microbiota including the biofilm composition. 189
Semi-automatic Approach to Estimate the Degree of Non-alcoholic Fatty Liver Disease (NAFLD) from Ultrasound Images 185
Blood flow changes in hepatocellular carcinomas after the administration of Thaliodomide by reperfusion kinetics during microbubble infusion: Preliminary results. 181
Hepatic cancer stem cells and drug resistance: relevance in targeted therapies of hepatocellular carcinoma 179
MiR-3201 as a Prognostic Blood Biomarker for Curative Treatments in Hepatocellular Carcinoma 178
Changing molecular epidemiology of hepatitis C virus infection in Northeast Italy. 177
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. 176
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis. 174
Cohort effect of HCV infection in liver cirrhosis assessed by a 25 years study 173
Antibiotics and Liver Cirrhosis: What the Physicians Need to Know 173
Repeated double cross-validation applied to the PCA-LDA classification of SERS spectra: a case study with serum samples from hepatocellular carcinoma patients 171
A comparative characterization of the circulating miRNome in whole blood and serum of HCC patients 170
Hepatitis B virus genotypes, core promoter variants, and precore stop codonvariants in patients infected chronically in North-Eastern Italy. 169
Clinical patterns of hepatocellular carcinoma in non alcoholic fatty liver disease: A multicenter prospective study 168
The Next Generation Sequencing (NGS) platform in the assessment of the gut microbiota in bariatric surgery. 166
Visual impairments and attention in parkinson's disease 162
Distribution of stem cells and cancer stem cells markers in liver pathologies and their indication to the response of therapy 162
Gene expression of ABC proteins in hepatocellular carcinoma, perineoplastic tissue and liver diseases 160
The plasticity of the stem cells in the hepatocarcinogenesis and metastasis: study in vitro and in vivo 160
Stem cells in the development of hepatocellular carcinoma: identification and expression 159
HLA-G regulatory polymorphisms are associated with susceptibility to HCV infection 159
Spleen Stiffness Probability Index (SSPI): A simple and accurate method to detect esophageal varices in patients with compensated liver cirrhosis 158
Weighted miRNA co-expression networks analysis identifies circulating miRNA predicting overall survival in hepatocellular carcinoma patients 158
High fecal calprotectin levels are associated with SARS-CoV-2 intestinal shedding in COVID-19 patients: A proof-of-concept study 157
Treatment options in Western hepatocellular carcinoma: A prospective study of 224 patients 156
Cross talk between multipotent stem-like cells and cancer cells in hepatocellular carcinoma 153
PREVALENCE OF CHRONIC LIVER-DISEASE IN THE GENERAL-POPULATION OF NORTHERN ITALY - THE DIONYSOS STUDY 152
Analysis of p53 and ras gene mutations in hepatocellular carcinoma from a Western country 150
Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients 147
null 146
Deep brain stimulation of the subthalamus: Neuropsychological effects 146
Spontaneous rectal perforation in a patient with SARS–CoV-2 infection 144
null 143
The role of elastography in alcoholic liver disease: fibrosis staging and confounding factors, a review of the current literature 142
Systematic review and meta-analysis on the adverse events of rimonabant treatment: considerations for its potential use in hepatology. 2009 Oc FI, 9;9:75. 141
Drug-induced acute cholestatic liver damage in a patient with mutation of UGT1A1 140
Diverticular Disease and Rifaximin: An Evidence-Based Review 138
COVID-19-Induced Thrombosis in Patients without Gastrointestinal Symptoms and Elevated Fecal Calprotectin: Hypothesis Regarding Mechanism of Intestinal Damage Associated with COVID-19 138
Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease 136
Clinical update on non-alcoholic fatty liver disease and steatohepatitis 136
Alanine aminotransferase and spleno-portal dynamics affect spleen stiffness measured by point shear-wave elastography in patients with chronic hepatitis C in the absence of significant liver fibrosis 135
Evaluation with contrast enhanced US of perfusion changes in untreatable hepatocellular carcinoma after thalidomide administration: preliminary results 134
null 133
Comparison between hepatocellular carcinoma prognostic scores: A 10-year single-center experience and brief review of the current literature 133
Aspirin and Infection: A Narrative Review 132
Human leucocyte interferon-alpha in the treatment of chronic hepatitis C 130
null 129
null 129
null 125
Severity of liver disease with different hepatitis C viral clones. 124
Peritoneal Tuberculosis during Infliximab Treatment in a Patient with Ulcerative Colitis Despite a Negative Quantiferon Test 124
Circulatory mirna as a biomarker for therapy response and disease-free survival in hepatocellular carcinoma 123
Optimization of hepatological clinical guidelines interpretation by large language models: a retrieval augmented generation-based framework 122
A story of liver and gut microbes: How does the intestinal flora affect liver disease? A review of the literature 122
Behind the Decrease of Liver Stiffness After Successful Hepatitis C Virus Eradication with Direct-Acting Antiviral Agents 120
null 119
Cirrosi biliare primitiva (CBP) asintomatica: trattamento con acido ursidesossicolico (UDCA). Risultati preliminari dopo 12 mesi. 118
Spontaneous porto-femoral shunting in long-standing portal hypertension 118
Clinical and virological features of acute HBV-related hepatitis in southern vietnam 117
Antibody pattern of HCV infection and hepatocellular carcinoma in Itakly: A case control study 115
Optimization of point-shear wave elastography by skin-to-liver distance to assess liver fibrosis in patients undergoing bariatric surgery 115
Characterization of focal liver lesions by pulse inversion harmonic imaging (PIHI) with Levovist in patients with cirrhosis. 114
MicroRNAs Related to TACE Treatment Response: A Review of the Literature from a Radiological Point of View 113
null 110
null 110
PNPLA3 Polymorphism Is Inversely Correlated with Aortic Stiffness in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease Without Fibrosis 109
Incidence and natural history of hepatocellular carcinoma and liver cirrhosis in Italy. A lesson from Trieste 109
Scelte terapeutiche e trattamento con sorafenib nell'epatocarcinoma: Analisi finale dello studio GIDEON in Italia 109
null 107
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 107
Predictors of Hepatocellular Carcinoma Early Recurrence in Patients Treated with Surgical Resection or Ablation Treatment: A Single-Center Experience 106
null 105
Evaluation of liver parenchymal blood flow with contrast-enhanced US: preliminary results in healthy and cirrhotic patients 105
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 105
The mRNA Distribution of Cancer Stem Cell Marker CD90/Thy-1 Is Comparable in Hepatocellular Carcinoma of Eastern and Western Populations 102
null 101
null 101
Calprotectin and SARS-CoV-2: A brief-report of the current literature 101
Totale 16.864
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.996
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.996
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.530 0 0 0 0 213 233 184 198 106 215 120 261
2021/20221.868 60 98 226 204 58 133 103 126 213 167 103 377
2022/20232.513 216 280 167 346 224 454 55 263 321 38 96 53
2023/20241.574 116 90 73 101 171 135 270 314 30 50 130 94
2024/20253.648 64 71 199 364 325 336 318 189 472 490 377 443
2025/20263.687 1.124 555 696 921 391 0 0 0 0 0 0 0
Totale 22.820